Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve Napper

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical & Experimental Optometry|February 27, 2003
Scheduling of controlled substances in Australia and New ZealandGenevieve Napper, Julie Albeitz, Ian Douglas
Clinical & Experimental Optometry|October 10, 2006
Ocular therapeuticsGenevieve Napper, Ian Douglas, Julie Albietz
Clinical & Experimental Optometry|February 22, 2007
Ocular therapeuticsJulie Albietz, Ian Douglas, Genevieve Napper
Clinical & Experimental Optometry|January 2, 2004
Preservative and antibiotic toxicity to the ocular surfaceGenevieve Napper, Ian Douglass, Julie Albietz
Clinical & Experimental Optometry|April 27, 2004
Ocular therapeuticsJulie Albietz, Ian Douglas, Genevieve Napper
Clinical & Experimental Optometry|May 31, 2007
Ocular therapeuticsJulie Albietz, Ian Douglas, Genevieve Napper
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|June 15, 2005
Evaluation of Melbourne Edge Test contrast sensitivity measures in the visually impairedJames S Wolffsohn, Frank Eperjesi, Genevieve Napper
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 20, 2004
Normative contrast sensitivity values for the back-lit Melbourne Edge Test and the effect of visual impairmentFrank Eperjesi, James Wolffsohn, Jason Bowden, et al.
Clinical & Experimental Optometry|October 26, 2007
Infection control guidelines for optometrists 2007Carol Lakkis, Ka-Yee Lian, Genevieve Napper, et al.
Clinical & Experimental Optometry|September 18, 2009
Influenza A(H1N1) and infection control guidelines for optometristsPatricia M Kiely, Ka-Yee Lian, Genevieve Napper, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical & Experimental Optometry|February 27, 2003
Scheduling of controlled substances in Australia and New ZealandGenevieve Napper, Julie Albeitz, Ian Douglas
Clinical & Experimental Optometry|October 10, 2006
Ocular therapeuticsGenevieve Napper, Ian Douglas, Julie Albietz
Clinical & Experimental Optometry|February 22, 2007
Ocular therapeuticsJulie Albietz, Ian Douglas, Genevieve Napper
Clinical & Experimental Optometry|January 2, 2004
Preservative and antibiotic toxicity to the ocular surfaceGenevieve Napper, Ian Douglass, Julie Albietz
Clinical & Experimental Optometry|April 27, 2004
Ocular therapeuticsJulie Albietz, Ian Douglas, Genevieve Napper
Clinical & Experimental Optometry|May 31, 2007
Ocular therapeuticsJulie Albietz, Ian Douglas, Genevieve Napper
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|June 15, 2005
Evaluation of Melbourne Edge Test contrast sensitivity measures in the visually impairedJames S Wolffsohn, Frank Eperjesi, Genevieve Napper
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 20, 2004
Normative contrast sensitivity values for the back-lit Melbourne Edge Test and the effect of visual impairmentFrank Eperjesi, James Wolffsohn, Jason Bowden, et al.
Clinical & Experimental Optometry|October 26, 2007
Infection control guidelines for optometrists 2007Carol Lakkis, Ka-Yee Lian, Genevieve Napper, et al.
Clinical & Experimental Optometry|September 18, 2009
Influenza A(H1N1) and infection control guidelines for optometristsPatricia M Kiely, Ka-Yee Lian, Genevieve Napper, et al.
Pageof 2